Medopad

Medopad is a British healthcare technology company enabling connected care.

Medopad Ltd is a British healthcare technology company enabling connected care. Headquartered in London, UK, it's the first digital health company to have solutions recognised by the NHS as a Standard of Care. KPMG recently named Medopad a $1B Health Tech company in the making. With its AI division, Medopad leverages its platform for new machine learning techniques that address some of the challenges associated with early detection of life-threatening health conditions or patient misdiagnosis. Medopad is CE approved, registered with the FDA and HIPAA compliant. Clients include large hospital groups and pharmaceutical companies, and since 2012, Medopad has been a supplier to the NHS. Amongst its client base are: Bayer, Johnson & Johnson, Novartis, HCA (the world’s largest private hospital group), Barts Health (the UK's largest NHS Trust), Royal Free (second largest NHS Trust) and many more. Medopad has attracted significant media coverage, including Bloomberg, The Economist, The Financial Times and BBC World News. Among Medopad's institutional investors are Bayer Pharmaceutical, Bupa and Colina.